Advertisement
Why the best material for a homemade coronavirus face mask is hard to identify

Why the best material for a homemade coronavirus face mask is hard to identify

Variables in fabrics, fit, and user behavior can influence how well a mask might block the virus’s spread.
How the coronavirus will transform science

How the coronavirus will transform science

Thought leaders in life sciences weigh in on lessons learned amid the COVID-19 pandemic
Searching for a coronavirus cure in the blood

Searching for a coronavirus cure in the blood

Scientists look to convalescent plasma, hyperimmune therapy, and monoclonal antibodies to treat COVID-19.
Clinical trial for ruxolitinib planned in fight against COVID-19

Clinical trial for ruxolitinib planned in fight against COVID-19

Treatment for rare blood cancers could temper cytokine storm in people with severe forms of the disease.
Plastic bag bans rolled back for COVID-19

Plastic bag bans rolled back for COVID-19

Regulators are restricting reusable bags over worries they might harbor virus.
Grad students tell of the coronavirus’s impact

Grad students tell of the coronavirus’s impact

Delayed postdoc opportunities. Canceled commencement. Graduate students in chemistry describe how the COVID-19 pandemic has affected their work and lives.
Will the coronavirus help mRNA and DNA vaccines prove their worth?

Will the coronavirus help mRNA and DNA vaccines prove their worth?

As gene-based vaccines are being designed and tested at unprecedented speeds to fight COVID-19, scientists wonder if this will be the technology’s make-or-break moment.
Chemistry faculty cope with coronavirus shutdowns

Chemistry faculty cope with coronavirus shutdowns

With university labs shuttered by COVID-19, chemistry faculty are getting a crash course in how to stay productive.
Companies are racing to develop COVID-19 tests for the US. Will they help?

Companies are racing to develop COVID-19 tests for the US. Will they help?

With a diagnostic backlog hampering disease control efforts, scientists are turning to CRISPR and other technologies to bridge the gap
Novel coronavirus thought to have jumped to humans via pangolins

Novel coronavirus thought to have jumped to humans via pangolins

Trafficked scaly anteaters found to carry coronaviruses related to SARS-CoV-2.
Meet Sheng Ding, who is tackling COVID-19 as director of China’s Global Health Drug Discovery Institute

Meet Sheng Ding, who is tackling COVID-19 as director of China’s Global Health Drug Discovery Institute

The chemist wants the Gates Foundation–backed institute to share its expertise during the coronavirus pandemic and advocate for public health
CAS curates dataset of antiviral compound leads with potential activity against COVID-19

CAS curates dataset of antiviral compound leads with potential activity against COVID-19

Open-access collection contains nearly 50,000 chemical compounds from the CAS Registry
Journal publishers promote flexibility during COVID-19 pandemic

Journal publishers promote flexibility during COVID-19 pandemic

Editors in Europe and the US plan to work with authors whose lives and labs have been disrupted by the novel coronavirus
What do we know about the novel coronavirus’s 29 proteins?

What do we know about the novel coronavirus’s 29 proteins?

These biomolecules could hold clues to why the virus is so infectious and to how to stop it
Coronavirus starts to weigh on industry

COVID-19 to delay clinical trials

Drugmakers want to keep trials going but acknowledge that medical resources are strained
Coronavirus starts to weigh on industry

Jen Heemstra on building your resilience

C&EN advice columnist offers 4 tips on adapting to times of uncertainty
Coronavirus starts to weigh on industry

Coronavirus starts to weigh on industry

Auto manufacturing is the first sector to halt demand for chemicals
COVID-19 mostly behind it, China’s chemical industry struggles to rev up

COVID-19 mostly behind it, China’s chemical industry struggles to rev up

Lingering logistic problems and a sputtering economy mean hard times for companies
Chemical industry welcomes leniency from US EPA during coronavirus response

Chemical industry welcomes leniency from US EPA during coronavirus response

Activists say broad lack of enforcement threatens safety
What can initial remdesivir data tell us about tackling COVID-19?

What can initial remdesivir data tell us about tackling COVID-19?

Gilead Sciences’ antiviral is in multiple late-stage trials to treat coronavirus infections. Don’t expect a home run, say infectious disease experts
US stimulus bill includes funding for coronavirus research

US stimulus bill includes funding for coronavirus research

The National Institutes of Health receives the vast majority of the support
Emory-discovered antiviral is poised for COVID-19 clinical trials

Emory-discovered antiviral is poised for COVID-19 clinical trials

The nucleoside inhibitor has advantages over Gilead’s remdesivir but has yet to be tested in humans
Coronavirus puts spotlight on chloroquine, but many questions remain

Coronavirus puts spotlight on chloroquine, but many questions remain

Old anti-malarial drugs are tested as potential treatments for COVID-19
Tension but also harmony over COVID-19 in Europe’s chemical industry

Tension but also harmony over COVID-19 in Europe’s chemical industry

Italian workers threaten to strike, but German, UK companies and workers pull together
China’s contract research firms rebound after coronavirus

China’s contract research firms rebound after coronavirus

Chemistry CROs are back in business as rest of world starts to lock down
Chemical firms say they want to keep going

Chemical firms say they want to keep going

Industry is deemed essential critical infrastructure by federal and state governments
Chemistry departments deal with coronavirus closures

Chemistry departments deal with coronavirus closures

Amid university shutdowns worldwide, professors and students adjust what social distancing means for lab scientists
Crystal structures of the novel coronavirus protease guide drug development

Crystal structures of the novel coronavirus protease guide drug development

Medicinal chemists focus on the main protease of SARS-CoV-2 to develop antiviral treatments for the virus causing COVID-19
Tips for teaching in the time of coronavirus

Tips for teaching in the time of coronavirus

Veterans of teaching chemistry online offer advice for professors challenged by the COVID-19 pandemic
3-D printing firms rise to coronavirus challenge

3-D printing firms rise to coronavirus challenge

Companies are making their machines and expertise available to hospitals in need of parts
What is hand sanitizer, and does it keep your hands germ-free?

What is hand sanitizer, and does it keep your hands germ-free?

Useful when you don’t have access to a sink and some soap, hand sanitizers have become a hot commodity in the face of COVID-19
Ginkgo opens facilities to help COVID-19 coronavirus response

Ginkgo opens facilities to help COVID-19 coronavirus response

Boston biotech firm is making its discovery and production service available to firms working on diagnostics, treatments, and vaccines
Stepping up to the hand sanitizer shortage

Stepping up to the hand sanitizer shortage

Chemical companies, breweries, and perfumeries take to making and donating a vital commodity in short supply
No evidence to support link between ibuprofen and COVID-19, experts say

No evidence to support link between ibuprofen and COVID-19, experts say

WHO does not recommend against taking the drug for fever caused by novel coronavirus infection
How small chemical company leaders are dealing with the coronavirus

Shortage of RNA extraction kits hampers efforts to ramp up COVID-19 coronavirus testing

Qiagen vows to ramp up production of kits as scientists turn to social media to plea for donations
How small chemical company leaders are dealing with the coronavirus

Sanofi, Regeneron test arthritis drug against COVID-19

New study explores whether dampening IL-6 could address serious coronavirus infections
How small chemical company leaders are dealing with the coronavirus

BioNTech joins coronavirus vaccine race

The German firm will work with Fosun Pharma and Pfizer to develop an mRNA vaccine for COVID-19
COVID-19 coronavirus weighs on economy, chemicals

COVID-19 coronavirus weighs on economy, chemicals

Chemical makers and oil producers are pulling back on production, reconsidering investments
How small chemical company leaders are dealing with the coronavirus

How small chemical company leaders are dealing with the coronavirus

Specialty chemical CEOs are rolling with the punches to keep their firms going

How we know disinfectants should kill the COVID-19 coronavirus

The novel virus is one of the easiest virus types to deactivate, though SARS-CoV-2–specific data are lacking

Can old drugs take down a new coronavirus?

Several approved and well-studied small molecules could be repurposed as treatments for COVID-19
Podcast: How the coronavirus could disrupt the drug supply

Coronavirus hits Europe

Chemical makers brace for a slowdown on the continent
Podcast: How the coronavirus could disrupt the drug supply

Podcast: How the coronavirus could disrupt the drug supply

Hear what C&EN’s pharmaceutical editors have learned about how the coronavirus is affecting drug production in China and across the globe
Chemists work around coronavirus restrictions

Chemists work around coronavirus restrictions

C&EN looks at how scientists are adapting to travel restrictions and working from home
Coronavirus forces cancellations of scientific meetings

Coronavirus forces cancellations of scientific meetings

Spring lineup of conferences and events frequented by chemists is slashed
ACS cancels spring national meeting in Philadelphia

ACS cancels spring national meeting in Philadelphia

Concerns over the spread of the novel coronavirus leads to decision
$8.3 billion allocated for US coronavirus response

$8.3 billion allocated for US coronavirus response

Congress opts for open-ended support for federal and local agencies
Researchers in China report structure of the novel coronavirus bound to its human target

Researchers in China report structure of the novel coronavirus bound to its human target

The structure shows the first steps of SARS-CoV-2 infection, and could help in drug discovery
Coronavirus cancels chemical events

Coronavirus cancels chemical events

Petrochemical and pharma meeting organizers say travel was becoming too difficult; ACS spring meeting is still on
Faulty probes are to blame for CDC coronavirus testing woes

Faulty probes are to blame for CDC coronavirus testing woes

The tests can still be used, CDC says, as urgency over possible outbreak grows
China’s new place on the front lines of diagnosing and treating coronavirus disease

China’s new place on the front lines of diagnosing and treating coronavirus disease

Industry watchers say the effort is unprecedented and would not have been possible during the last SARS outbreak
Gilead and Moderna lead on coronavirus treatments

Gilead and Moderna lead on coronavirus treatments

Gilead has a head start on an antiviral, while Moderna is pursuing a novel mRNA vaccine
Chemical firms see light at end of coronavirus tunnel

Chemical firms see light at end of coronavirus tunnel

Facilities are reopening in China but spread of virus outside China is raising concerns
Diagnosing the novel coronavirus leads to trade offs

Diagnosing the novel coronavirus leads to trade offs

Medical workers in China weigh the advantages and disadvantages of nucleic acid lab tests and CT lung scans
Structure of novel coronavirus spike protein solved in just weeks

Structure of novel coronavirus spike protein solved in just weeks

Cryo-EM structure of key coronavirus protein could help develop vaccines against the virus
Biotech firms consider contingency plans as the coronavirus outbreak hits CROs

Biotech firms consider contingency plans as the coronavirus outbreak hits CROs

The industry’s reliance on China-based firms for chemistry services is in the spotlight
What we do and don't know about novel coronavirus

What we do and don't know about novel coronavirus

Scientists race to characterize, build vaccines and treatments for the virus as thousands fall ill
Novel coronavirus puts drug chemical industry on alert

Novel coronavirus puts drug chemical industry on alert

Firms signal preparedness, but warn that prolonged plant closures and travel restrictions may cause significant disruption
Two groups use artificial intelligence to find compounds that could fight the novel coronavirus

Two groups use artificial intelligence to find compounds that could fight the novel coronavirus

One group identifies an existing drug, the other finds 6 novel molecules, but the consequences of reporting possibly helpful molecules are unclear
Coronavirus shadows China’s chemical industry

Coronavirus shadows China’s chemical industry

Executives in China and the US see a manageable crisis but also many unknowns
Drug firms mobilize to combat novel coronavirus outbreak

Drug firms mobilize to combat novel coronavirus outbreak

Development of diagnostics, vaccines, and treatments is underway
Biotech firms to tackle coronavirus

Biotech firms to tackle coronavirus

Companies are quick to announce plans to diagnose or treat the novel coronavirus
Biotech firms to tackle coronavirus

Podcast: Why do I have to get a flu shot every year?

Influenza evolution experts tell Stereo Chemistry what makes the virus so good at evading our immune system

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN